MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,530 | +180.2% | 1,476 | +343.2% | 0.00% | – |
| Q2 2023 | $76,923 | +24.0% | 333 | +30.1% | 0.00% | – |
| Q1 2023 | $62,010 | -58.3% | 256 | -50.0% | 0.00% | – |
| Q4 2022 | $148,581 | +132.2% | 512 | -47.6% | 0.00% | – |
| Q3 2022 | $64,000 | -9.9% | 977 | -1.1% | 0.00% | – |
| Q2 2022 | $71,000 | -30.4% | 988 | -4.8% | 0.00% | – |
| Q1 2022 | $102,000 | +30.8% | 1,038 | +11.0% | 0.00% | – |
| Q4 2021 | $78,000 | +11.4% | 935 | +8.0% | 0.00% | – |
| Q3 2021 | $70,000 | +133.3% | 866 | +183.0% | 0.00% | – |
| Q2 2021 | $30,000 | 0.0% | 306 | +17.2% | 0.00% | – |
| Q1 2021 | $30,000 | -16.7% | 261 | -19.4% | 0.00% | – |
| Q4 2020 | $36,000 | +125.0% | 324 | +134.8% | 0.00% | – |
| Q3 2020 | $16,000 | +45.5% | 138 | +38.0% | 0.00% | – |
| Q2 2020 | $11,000 | -68.6% | 100 | -80.9% | 0.00% | – |
| Q1 2020 | $35,000 | – | 523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |